Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Accuray and Erasmus Medical Center Sign Master Research and Collaboration Agreement
Date:6/26/2012
SUNNYVALE, Calif., June 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master research and collaboration agreement with Erasmus Medical Center (MC), a leading research center in Rotterdam, the Netherlands and the largest of the eight university medical centers in the country. Accuray and Erasmus MC will partner on cutting-edge research in radiation oncology with the goal of advancing treatment technology and providing healthcare professionals with the most effective tools for patient care.
"Erasmus MC has a long history of collaborating with Accuray and we are pleased to continue our partnership to advance radiation oncology," said Professor Peter C. Levendag, M.D., Ph.D., Chairman of the Radiation Oncology Department at Erasmus MC. "Our Center's extensive technical research and clinical experience with the CyberKnife System has helped us see and understand the many benefits that radiosurgery offers to cancer patients. We are pleased to reaffirm our commitment to working together to further validate the science of radiosurgery and clinical applications of the CyberKnife System."
Accuray has been working together with Erasmus MC on research initiatives since the Center installed its first CyberKnife® Robotic Radiosurgery System in 2004, making them the fourth site in the Europe India Middle East and Africa (EIMEA) region to install a CyberKnife System at that time. To date, Erasmus MC has treated more than 1,000 patients with the CyberKnife System, performed a substantial amount of clinical research on the use of the CyberKnife System, and authored more than 20 technical and clinical publications in peer-reviewed journals and several book chapters. The Cen
'/>"/>
| SOURCE Accuray Incorporated Copyright©2012 PR Newswire. All rights reserved |
Related medicine technology :
1. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
2. Accuray Announces Results for Third Quarter Fiscal 2012
3. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
4. Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
5. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
6. Accuray Incorporated to Speak at Wells Fargo Healthcare Conference
7. Accuray Rolls Out Comprehensive Customer Service Program in Japan
8. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
9. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
10. Medical Device Developers - Network at BIOMEDevice Boston Next Week
11. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
Post Your Comments:
(Date:5/19/2013)... OAKLAND, Calif. , May 20, 2013 Whole-cell ... than acellular pertussis vaccines during a large recent outbreak, ... Pediatrics. Whole-cell pertussis vaccines, also called DTwP, ... associated with safety concerns that ultimately led to the ... DTaP. By the late 1990s, the United ...
(Date:5/18/2013)... ORLANDO, Fla. , May 18, 2013 ... and are considered the most sensitive method for ... completely effective in preventing cancer cases 3 . EndoChoice ... its new Fuse™ system significantly improves the accuracy of ... missed by colonoscopists. EndoChoice will be discussing these clinical ...
(Date:5/18/2013)... , May 18, 2013 Faruqi & ... is investigating potential securities fraud at AVEO Pharmaceuticals, ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... its executives violated federal securities laws by issuing ... Phase III drug trials for Tivopath (tivozanib) (titled ...
Breaking Medicine Technology:Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2[0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak[0] New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy[0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
... Aug. 16 Adeona Pharmaceuticals, Inc. (AMEX: AEN ... recent achievements. Adeona will hold a conference ... discuss these results. James S. Kuo, M.D., M.B.A., Adeona,s Chief ... please call toll free: 1-800-860-2442 (US); international dial-in: ...
... Calif., Aug. 12 Founder of the Dermatology Institute, Peter Rullan, ... Perfect™ treatments to his patients with the purchase of the ... excited to add this new service for our patients," Dr. Rullan ... wanted to find a system that not only met my patients, ...
Cached Medicine Technology:Adeona Announces Second Quarter 2010 Profitability and Achievements 2Adeona Announces Second Quarter 2010 Profitability and Achievements 3Adeona Announces Second Quarter 2010 Profitability and Achievements 4Adeona Announces Second Quarter 2010 Profitability and Achievements 5Adeona Announces Second Quarter 2010 Profitability and Achievements 6Chula Vista's Dr. Peter Rullan Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients 2(Date:5/20/2013)... 20, 2013 In order to prepare for ... wellness team from DrSmartphoneMD launched an article series to raise ... The series launched with the precautions that need ... the DrSmartphoneMD program are not one of the 3.5 million ... more than 90% of all skin cancer cases are associated ...
(Date:5/20/2013)... Angeles, CA (PRWEB) May 20, 2013 ... just been released to the public creating a ... gain access to this elite business training. WealthSpringMarketing.com's ... course as well as an exclusive bonus. , ... for providing elite business training to individuals serious ...
(Date:5/20/2013)... 2013 Parker Waichman LLP, a national ... injured by defective drugs, has filed a lawsuit on ... use of the diabetes drug medication Actos (pioglitazone) ... April 30, 2013, in the U.S. District Court for ... it is one of thousands of cases pending in ...
(Date:5/20/2013)... West Palm Beach, FL (PRWEB) May 20, 2013 ... Schwartz is honored to be recognized as a “Top Doc” ... of The Palm Beacher Magazine. , The Palm Beacher ... published a list of “Top Docs” in the May/June 2013 ... specialties. Featuring the best restaurants and dining, events, things to ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Mirena ... in the multidistrict litigation recently established in U.S. District ... reports. According to court records, the litigation’s first ... time appointments to Plaintiff’s leadership positions were discussed. ... in the Southern District of New York, all of ...
Breaking Medicine News(10 mins):Health News:Combat Skin Cancer In Summer Months 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3[0] Combat Skin Cancer In Summer Months[0] Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com[0] Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man[0] Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine[0] Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation
... advertises during shows watched by typical U.S. teens, analysis ... TV shows that attract a significant proportion of teenage ... for alcohol, new research has found. , Using Nielsen ... for alcohol that aired on cable TV from 2001 ...
... ... , with the influx of new patients entering the healthcare system under Obama,s proposed ... ... Journal of General Internal Medicine, healthcare planners projected that physician surpluses of both U.S. ...
... ... ready to heat and eat meals, are applauding the recent TIME magazine cover story that ... properly balanced meals. , ... VA (PRWEB) August 29, 2009 -- Officials at Diet-to-Go, a national leader in deliciously healthy, ...
... untreated Ugandans infected with type D were affected, study ... subtype of HIV a person has may determine their ... report. , Cognitive difficulties, even dementia, are a common ... Africa, researchers led by Dr. Ned Sacktor noted that ...
... , , , , ... 1 , , HARRISBURG, Pa., Aug. 28 ... people who live or work within a 10-mile radius of Pennsylvania,s five nuclear ... tablets that were distributed previously by the commonwealth will expire on Aug. 31 ...
... help physicians predict a patient,s risk of dying from chronic ... assess the severity of a patient,s illness to determine the ... bronchitis, is a major public health problem and it is ... study of the ADO index is published in the August ...
Cached Medicine News:Health News:Alcohol Ads on Cable TV Reach Young Audiences 2Health News:Alcohol Ads on Cable TV Reach Young Audiences 3Health News:Foreign Physician Growth in the U.S. and the Impact on Medical Credentialing 2Health News:Foreign Physician Growth in the U.S. and the Impact on Medical Credentialing 3Health News:Diet-to-Go Asks: Isn't it TIME You Listened to the Facts About Weight Loss? 2Health News:Diet-to-Go Asks: Isn't it TIME You Listened to the Facts About Weight Loss? 3Health News:Pennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power Plants 2Health News:Pennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power Plants 3Health News:New tool to predict the risk of death in COPD may help physicians to individualize treatment 2Alcohol Ads on Cable TV Reach Young AudiencesForeign Physician Growth in the U.S. and the Impact on Medical CredentialingDiet-to-Go Asks: Isn't it TIME You Listened to the Facts About Weight Loss?Dementia More Likely With One Subtype of HIVPennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power PlantsNew tool to predict the risk of death in COPD may help physicians to individualize treatment
... of three software components that comprise ... ,Three software components comprise the SmartPill ... software, SmartPill Data Receiver software and ... are integrated and indispensable parts of ...
... Analysis for POLYGRAM NET™ works with the ... analyze multichannel EGG signals. The EGG analysis ... by performing an automatic electrode impedance check ... beginning of a recording. If the electrode ...
... the foundation and supporting framework for ... extremely versatile software supports the reporting, ... the GI diagnostic testing procedures including ... ambulatory pH testing, esophageal manometry, bile ...
Symbia T, a TruePoint SPECTCT system, combines a dual-detector variable angle gamma camera with a CT scanner optimized for rapid, accurate attenuation correction of the nuclear data....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |